Latest Food & Drug Administration news
Vijoice Granted First Approval for Treatment of PROS
posted April 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Axicabtagene Ciloleucel Approved for Second-Line Treatment of LBCL
posted April 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACC: Bleeding Risk Lower With Tranexamic Acid in Noncardiac Surgery
New Law Allows FDA to Police E-Cigarettes Made With Synthetic Nicotine
posted April 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pretty young hipster woman vape ecig, vaping device at the sunset. Toned image.
FDA Advisers Weigh COVID-19 Booster Shots for Fall
posted April 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
FDA Now Providing Daily Updates on Adverse Events 
FDA Suspends U.S. License of Chikungunya Vaccine 
FDA Urges Restrictions, Education on Illegal 7-OH Opioid Products 
Federal Agencies Working to Create Uniform Definition of Ultra-Processed Foods Monthly Specialist Briefings
Stay Connected
